Search

everythinglearnresearchcommunity

for

Search:↓

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

JAK inhibitors are effective for long-term management of alopecia areata.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Upadacitinib effectively treats psoriasis and lichen planus together.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Pulsed dye laser treatment was effective for a skin condition resistant to other treatments.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Upadacitinib effectively treated severe hair loss in a child.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Janus kinase inhibitors may help treat lichen planopilaris.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.